@article{ATM6043,
author = {Omar Mahmoud and Bruce G. Haffty},
title = {Regional nodal management in the light of the AMAROS trial},
journal = {Annals of Translational Medicine},
volume = {3},
number = {7},
year = {2015},
keywords = {},
abstract = {The last decade witnessed the gradual adoption of sentinel lymph node biopsy (SLNB) to stage the axilla of breast cancer (BC) patients presenting with clinically negative lymph nodes; aiming to minimize the complications of the formal (gold standard) axillary lymph node dissection (ALND). Although abandoning ALND in pathologically negative sentinel node (SN) became the current standard of care, a similar consensus remains lacking in patients with positive SN.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/6043}
}